Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Smile Hair Clinic: Redefining Hair Transplantation in Turkey
Healthcare & PharmaceuticalProduct Announcements

Smile Hair Clinic: Redefining Hair Transplantation in Turkey

January 20, 2025 1:32 AM

Smile Hair Clinic is proud to announce its position as a leader in the global hair transplant industry, offering world-class services that blend advanced medical expertise with the personalized care and affordability that Turkey is renowned for. Why Smile Hair Clinic?At Smile Hair Clinic, excellence is at the heart of everything we do. Our highly skilled surgeons, led by internationally recognized professionals, is dedicated to delivering...

Read more
Moderna Announces Updates on Pandemic Influenza Program
Healthcare & PharmaceuticalCompany Update

Moderna Announces Updates on Pandemic Influenza Program

January 17, 2025 4:28 PM

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR).The...

Read more
Introducing Aletheia Health Partners
Healthcare & PharmaceuticalCompany Update

Introducing Aletheia Health Partners

January 17, 2025 12:00 PM

In order to make the best decisions for a rural hospital, boards don't just need facts-they need a full view into the health of the facility. Which areas are struggling? Which ones offer potential for growth? Are there other issues beyond the obvious that are impacting hospital financials? Without comprehensive, up-to-date and transparent information, interpreted within a broader context, finding solutions can be more than challenging. They can...

Read more
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Healthcare & PharmaceuticalCompany Update

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

January 17, 2025 9:25 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for Medicare and Medicaid Services (CMS) has selected XIFAXAN® (rifaximin) 550 mg tablets as one of the medicines for the second round of negotiation as part of the Inflation Reduction Act with an initial price applicability in 2027 of the Drug Price Negotiation program.We look forward to engaging in...

Read more
Poikiloderma of Civatte Treatment Now Available at Skin & Laser Dermatology Center
Healthcare & PharmaceuticalCompany Update

Poikiloderma of Civatte Treatment Now Available at Skin & Laser Dermatology Center

January 17, 2025 9:00 AM

Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for Poikiloderma of Civatte, offering patients safe and effective options for addressing redness, pigmentation changes, and visible blood vessels.Poikiloderma of Civatte is a chronic skin condition characterized by a combination of redness (erythema), pigmentation changes (hyperpigmentation or hypopigmentation), and a visible network of small...

Read more
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Healthcare & PharmaceuticalRegulatory

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

January 17, 2025 9:00 AM

SAN DIEGO, CA / ACCESS Newswire / January 17, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), today announced that it had received written notification (the "Written Notification") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") that the Company is eligible for a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2)...

Read more
WCH Joins athenahealth's Marketplace Program to Provider Credentialing and State Licensure
Healthcare & PharmaceuticalPartnerships

WCH Joins athenahealth's Marketplace Program to Provider Credentialing and State Licensure

January 17, 2025 8:30 AM

WCH, a provider of billing and credentialing services, today announced an agreement with athenahealth, Inc. through the company's award-winning athenahealth® Marketplace program. Now available to athenahealth's growing network of healthcare providers, the newly integrated WCH provider credentialing and state licensure solutions enable access to a comprehensive suite of services for all your provider onboarding and maintenance needs. The...

Read more
Sober Safe Spot at Louisiana Culture Festival
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Sober Safe Spot at Louisiana Culture Festival

January 17, 2025 8:00 AM

We are excited to announce the arrival of Sober Safe Spot at the Louisiana Culture Festival!The Louisiana Culture Festival is a one-time event celebrating Cajun culture in advance of the widely anticipated 59th Super Bowl, hosted by the city of New Orleans. The festival is open to the entire New Orleans community, and serves as a prime opportunity to offer education, free resources, and instant support to those battling addiction and those in...

Read more
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates
Healthcare & PharmaceuticalCompany Update

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

January 17, 2025 7:30 AM

TORONTO, ON / ACCESS Newswire / January 17, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announced...

Read more
Onco-Innovations' Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells
Healthcare & PharmaceuticalCompany Update

Onco-Innovations' Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells

January 16, 2025 5:00 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed technology, a new class of Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors (the "Technology"), which was shown in a study1 to successfully prevent the regeneration of cancer cells, by disrupting DNA repair processes, making cancer cells more vulnerable to radiation therapy and thereby...

Read more
Introducing BenCura University
Healthcare & PharmaceuticalCompany Update

Introducing BenCura University

January 16, 2025 3:30 PM

At BenCura, continuous education and quality improvement form the cornerstone of our organization. In line with this commitment, we are excited to announce the launch of BenCura University in 2025-a new and innovative educational opportunity for our partner hospitals and skilled nursing facilities."As someone who comes from a family of educators, education has always been a fundamental aspect of my personal and professional growth," said...

Read more
IntusCare Increases Total Funding to Over $27M through Strategic Follow-On Financing
Healthcare & PharmaceuticalCompany Update

IntusCare Increases Total Funding to Over $27M through Strategic Follow-On Financing

January 16, 2025 11:00 AM

IntusCare, a leading provider of predictive analytics solutions for geriatric care, today announced it has raised $11.5 million in a strategic follow-on financing round. This latest investment brings the company's total funding to over $27 million, underscoring the strong market positioning of IntusCare's innovative approach to improving care outcomes for complex senior populations.The investment round was led by Deerfield Management, with...

Read more
ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards
Healthcare & PharmaceuticalAwards

ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards

January 16, 2025 7:45 AM

ModMed continues to dominate the field of physician practice electronic health record (EHR) software, earning top honors in the 2025 Black Book Research Awards across 11 medical specialties. Recognized for its ability to deliver tailored, innovative EHR solutions that meet the distinct needs of diverse physician practices, ModMed solidifies its position as the trusted choice for specialty care providers.ModMed's specialty-specific EHR solutions...

Read more
Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys
Healthcare & PharmaceuticalProduct Announcements

Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys

January 16, 2025 7:28 AM

Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products spanning the EU, US, and Canada, today announced the launch of ThymoTropin™, a revolutionary over-the-counter (OTC) solution for muscle growth, repair, and preservation. ThymoTropin™, powered by clinically validated thymol and carvacrol, represents a first-of-its-kind product targeting myostatin regulation, a critical mechanism for maintaining muscle mass and...

Read more
Javid Javdani Highlights the Intersection of Business and Health in San Diego
Healthcare & PharmaceuticalCompany Update

Javid Javdani Highlights the Intersection of Business and Health in San Diego

January 15, 2025 8:15 PM

Entrepreneur and community advocate Javid Javdani is shining a spotlight on the critical connection between business and health, emphasizing the need for local initiatives that empower small businesses and improve access to nutritious, high-quality food in San Diego. Known for his innovative approach to combining entrepreneurship with community well-being, Javdani urges residents and policymakers to focus on solutions that strengthen both public...

Read more
Adam Vibe Gunton: From IHOP Spiritual Awakening to America's Recovery Revolutionary
Healthcare & PharmaceuticalCompany Update

Adam Vibe Gunton: From IHOP Spiritual Awakening to America's Recovery Revolutionary

January 15, 2025 6:00 PM

With over 100,000 Americans dying yearly from opioid-related overdoses, one man believes he has the solution - and he's giving himself 10 years to prove it. "There's been crises in every generation, and every single one of them was solved," says Adam Vibe Gunton, founder of Recovered on Purpose. "There's no way that we're just going to be losing 100,000 people to opioids every year from here on out. It's not possible. It has to be...

Read more
U.S. Surpassed 48,000 Organ Transplants in 2024
Healthcare & PharmaceuticalCompany Update

U.S. Surpassed 48,000 Organ Transplants in 2024

January 15, 2025 1:15 PM

Today, the United Network for Organ Sharing (UNOS) announced that 48,149 organ transplants were performed in 2024, according to data from the Organ Procurement and Transplantation Network (OPTN). This is the first time the United States has ever performed more than 48,000 organ transplants in one year and represents a critical step in the nationwide effort to increase the number of lifesaving organ transplants while improving the system.On...

Read more
Oxycodone Misuse Prevention: Ken Pharmacy Launches Awareness Initiative
Healthcare & PharmaceuticalCompany Update

Oxycodone Misuse Prevention: Ken Pharmacy Launches Awareness Initiative

January 15, 2025 1:00 PM

Ken pharmacy, a leading healthcare service, today emphasized its commitment to responsible pain management and opioid stewardship. As part of this effort, the company is promoting awareness about the safe use of oxycodone, a prescription opioid pain reliever.Oxycodone is a vital medication for managing moderate to severe pain. However, its potential for misuse and addiction requires careful consideration. Ken Pharmacy is dedicated to supporting...

Read more
Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets
Healthcare & PharmaceuticalProduct Announcements

Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets

January 15, 2025 11:00 AM

TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa Pharmaceuticals, Inc. ("Handa") (6620.TWO) announced that its U.S. subsidiary, Handa Therapeutics, LLC (the "Company"), has acquired PHYRAGO™ (dasatinib) tablets, a U.S. Food and Drug Administration ("FDA") approved chronic myeloid leukemia treatment that was developed by Nanocopoeia, LLC. PHYRAGO™ is the first and only dasatinib product that can be co-administered with gastric acid-reducing...

Read more
Cellev8 Nutrition Teams Up With NFL Hall of Famer Andre Reed to Revolutionize Wellness, on and Off the Field
Healthcare & PharmaceuticalCompany Update

Cellev8 Nutrition Teams Up With NFL Hall of Famer Andre Reed to Revolutionize Wellness, on and Off the Field

January 15, 2025 10:30 AM

Cellev8 Nutrition Inc., a leader in natural health supplements, is proud to announce an exclusive partnership with NFL Hall of Famer Andre Reed. This collaboration marks a transformative step in athlete wellness, from the weekend warrior to professional levels looking to protect, enhance and assist their bodies from the cellular level daily.A Game-Changing PartnershipThe multi-year collaboration aims to raise awareness about the benefits of...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?